ArticleAntioxidants (Basel, Switzerland)2022

Targeting NRF2 Sensitizes Esophageal Adenocarcinoma Cells to Cisplatin through Induction of Ferroptosis and Apoptosis.

Farah Ballout et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.